Crotamine toxicity and efficacy in mouse models of melanoma
dc.contributor.author | Pereira, Alexandre | |
dc.contributor.author | Kerkis, Alexandre | |
dc.contributor.author | Hayashi, Mirian A. F. [UNIFESP] | |
dc.contributor.author | Pereira, Aparecida S. P. | |
dc.contributor.author | Silva, Fernando S. | |
dc.contributor.author | Oliveira, Eduardo B. | |
dc.contributor.author | Prieto da Silva, Alvaro R. B. | |
dc.contributor.author | Yamane, Tetsuo | |
dc.contributor.author | Radis-Baptista, Gandhi | |
dc.contributor.author | Kerkis, Irina | |
dc.contributor.institution | Butantan Inst | |
dc.contributor.institution | Vet Act Ltda Genet Aplicada | |
dc.contributor.institution | Virol Lab | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Univ Estado Amazonas | |
dc.contributor.institution | Univ Fed Ceara | |
dc.date.accessioned | 2016-01-24T14:17:12Z | |
dc.date.available | 2016-01-24T14:17:12Z | |
dc.date.issued | 2011-09-01 | |
dc.description.abstract | Objectives: Selective anticancer cell activity for both cell-penetrating and cationic antimicrobial peptides has previously been reported. As crotamine possesses activities similar to both of these, this study investigates crotamine's anticancer toxicity in vitro and in vivo.Research design and methods: in vitro cancer cell viability was evaluated after treatment with 1 and 5 mu g/ml of crotamine. in vivo crotamine cytotoxic effects in C57Bl/6J mice bearing B16-F10 primary cutaneous melanoma were tested, with two groups each containing 35 mice. the crotamine-treated group received 1 mu g/day of crotamine per animal, subcutaneously which was well tolerated; the untreated group received a placebo.Results: Crotamine at 5 mu g/ml was lethal to B16-F10, Mia PaCa-2 and SK-Mel-28 cells and inoffensive to normal cells. in vivo crotamine treatment over 21 days significantly delayed tumor implantation, inhibited tumor growth and prolonged the lifespan of the mice. Mice in the crotamine-treated group survived at significantly higher rates (n = 30/35) than those in the untreated group (n = 7/35) (significance calculated with the Kaplan-Meier estimator). the average tumor weight in the untreated group was 4.60 g but was only about 0.27 g in the crotamine-treated mice, if detectable.Conclusions: These data warrant further exploration of crotamine as a tumor inhibition compound. | en |
dc.description.affiliation | Butantan Inst, Ctr Appl Toxinol CAT CEPID, BR-05503900 São Paulo, Brazil | |
dc.description.affiliation | Butantan Inst, Genet Lab, BR-05503900 São Paulo, Brazil | |
dc.description.affiliation | Vet Act Ltda Genet Aplicada, Celltrovet, São Paulo, Brazil | |
dc.description.affiliation | Virol Lab, São Paulo, Brazil | |
dc.description.affiliation | Fed Univ São Paulo UNIFESP, Dept Pharmacol, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, Brazil | |
dc.description.affiliation | Univ Estado Amazonas, Natl Inst Sci & Technol Environm Energy & Biodive, Manaus, Amazonas, Brazil | |
dc.description.affiliation | Univ Fed Ceara, Inst Marine Sci, Fortaleza, Ceara, Brazil | |
dc.description.affiliationUnifesp | Fed Univ São Paulo UNIFESP, Dept Pharmacol, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.format.extent | 1189-1200 | |
dc.identifier | http://dx.doi.org/10.1517/13543784.2011.602064 | |
dc.identifier.citation | Expert Opinion On Investigational Drugs. London: Informa Healthcare, v. 20, n. 9, p. 1189-1200, 2011. | |
dc.identifier.doi | 10.1517/13543784.2011.602064 | |
dc.identifier.issn | 1354-3784 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/34038 | |
dc.identifier.wos | WOS:000293897900002 | |
dc.language.iso | eng | |
dc.publisher | Informa Healthcare | |
dc.relation.ispartof | Expert Opinion On Investigational Drugs | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf | |
dc.subject | antimicrobial peptides | en |
dc.subject | cancer cells selective toxicity | en |
dc.subject | cell-penetrating peptides | en |
dc.subject | chemotherapeutical compound | en |
dc.subject | tumor growth arrest | en |
dc.title | Crotamine toxicity and efficacy in mouse models of melanoma | en |
dc.type | info:eu-repo/semantics/article |